| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Sotirios Tsimikas | Q80167861 |
| Paul Ridker | Q7153226 | ||
| P2093 | author name string | James T Willerson | |
| P433 | issue | 8 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | C19-31 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients | |
| P478 | volume | 47 |
| Q36682671 | Abdominal obesity and metabolic syndrome |
| Q36715251 | Aging, frailty, and chemotherapy |
| Q36851683 | An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration |
| Q34100632 | Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis |
| Q34730419 | Are Additional Lipid Measures Useful? |
| Q36196297 | Association between Periodontopathogens and CRP Levels in Patients with Periodontitis in Serbia |
| Q37626645 | Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention |
| Q86049058 | Association of dehydroepiandrosterone sulfate, serum lipids, C-reactive protein and body mass index with age-related macular degeneration |
| Q35904776 | Association of somatic and cognitive depressive symptoms and biomarkers in acute myocardial infarction: insights from the translational research investigating underlying disparities in acute myocardial infarction patients' health status registry |
| Q36113651 | Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups |
| Q58492104 | Atherogenesis and Inflammation |
| Q51597663 | Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control study. |
| Q37500635 | Biomarkers in cardiovascular medicine |
| Q40100974 | Brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohort |
| Q58575852 | C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls |
| Q104076211 | C-reactive Protein Levels Are Higher in Patients with Fusiform Intracranial Aneurysms: A Case-Control Study |
| Q60297018 | C-reactive protein as a systemic marker of inflammation in periodontitis |
| Q42940082 | C-reactive protein is associated with cigarette smoking-induced hyperfiltration and proteinuria in an apparently healthy population |
| Q33961757 | C-reactive protein-mediated vascular injury requires complement. |
| Q37939984 | Chimeric aptamers in cancer cell-targeted drug delivery |
| Q89081455 | Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive Disorder |
| Q40274605 | Clinical implications of vulnerable plaque |
| Q61188002 | Comentarios bibliográficos |
| Q35674514 | Comparison of Lipoprotein-Associated Phospholipase A2 and High Sensitive C-Reactive Protein as Determinants of Metabolic Syndrome in Subjects without Coronary Heart Disease: In Search of the Best Predictor |
| Q33776221 | Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1). |
| Q38014565 | Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes. |
| Q34996608 | Differential associations between blood biomarkers of inflammation, oxidation, and lipid metabolism with varying forms of coronary atherosclerotic plaque as quantified by coronary CT angiography |
| Q21285000 | Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery |
| Q51278236 | Effect of consumption of a carob pod inositol-enriched beverage on insulin sensitivity and inflammation in middle-aged prediabetic subjects. |
| Q47994270 | Effects of G994T in the Lp-PLA2 gene on the plasma oxidized LDL level and carotid intima-media thickness in Japanese: the Shimane study |
| Q38680653 | Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study |
| Q37299877 | Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study |
| Q34713240 | Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction. |
| Q41375744 | Elevated high-sensitivity C-reactive protein in preterm infants with pulmonary colonization with Ureaplasma |
| Q33839384 | Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques |
| Q30404049 | Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome. |
| Q37362743 | Endothelial progenitor cells: markers of vascular reparative capacity |
| Q37004632 | Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin |
| Q79634887 | Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer |
| Q35958888 | Evaluation of serum sTWEAK and sCD163 levels in patients with acute and chronic coronary artery disease |
| Q36623897 | Females with angina pectoris have altered lipoprotein metabolism with elevated cholesteryl ester transfer protein activity and impaired high-density lipoproteins-associated antioxidant enzymes |
| Q33301643 | Genetic markers and biomarkers for age-related macular degeneration |
| Q43284567 | Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery |
| Q57245270 | Guía de práctica clínica para la valoración del riesgo cardiaco preoperatorio y el manejo cardiaco perioperatorio en la cirugía no cardiaca |
| Q34794633 | Hemodynamic and hormonal patterns of untreated essential hypertension in men and women |
| Q39837396 | High-sensitivity CRP is correlated with neurologic symptoms and plaque instability in patients with severe stenosis of the carotid bifurcation |
| Q36889170 | How can we prevent cardiovascular disease in diabetes |
| Q36299019 | Hypercholesterolemia among apparently healthy university students |
| Q52657156 | Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors. |
| Q39903699 | Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease |
| Q37986175 | Inflammation in atherosclerosis: a cause or a result of vascular disorders? |
| Q39004263 | Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease |
| Q37287058 | Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. |
| Q37277958 | Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients. |
| Q34443714 | Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies |
| Q37279061 | Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study |
| Q42431495 | Jay and Jeanie Schottenstein prize in cardiovascular science: predicting cardiovascular illnesses for the 21(st) century, and the unpredictable.. |
| Q35808874 | Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people |
| Q36913022 | Lipoprotein-associated phospholipase A(2) : review of its role as a marker and a potential participant in coronary endothelial dysfunction |
| Q36584772 | Metabolic biomarkers for predicting cardiovascular disease |
| Q34031701 | Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training |
| Q33741235 | Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2) |
| Q37184990 | Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patients |
| Q48861083 | No evidence of cardiovascular toxicity in workers exposed below 5 ppm carbon disulfide |
| Q38854433 | Novel biomarkers of coronary microvascular disease |
| Q37342253 | Novel insights into the role of cardiotrophin-1 in cardiovascular diseases |
| Q37735536 | OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators |
| Q59799757 | Peripheral Biomarker for Vascular Disorders |
| Q39625259 | Plasma procalcitonin and the risk of cardiovascular events and death: a prospective population-based study |
| Q48574197 | Pre-operative high sensitivity C-reactive protein and postoperative outcome in patients undergoing elective orthopaedic surgery. |
| Q50462667 | Predictive impact on medium-term mortality of hematological parameters in Acute Coronary Syndromes: added value on top of GRACE risk score. |
| Q40401335 | Preoperative Acute Inflammatory Markers as Predictors for Postoperative Complications in Primary Total Knee Arthroplasty |
| Q45948712 | Protein biomarker druggability profiling. |
| Q37207340 | Proteomic Biomarkers of Atherosclerosis |
| Q36787244 | Proteomics in atherothrombosis: a future perspective |
| Q37607422 | Psoriasis comorbidities |
| Q37304123 | Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. |
| Q37030253 | Red cell distribution width and neutrophil-to-lymphocyte ratio predict left ventricular dysfunction in acute anterior ST-segment elevation myocardial infarction |
| Q37387150 | Red cell distribution width, inflammatory markers and cardiorespiratory fitness: results from the National Health and Nutrition Examination Survey |
| Q42629551 | Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS |
| Q44911498 | Relation between red cell distribution width and severity of coronary artery disease in patients with acute myocardial infarction |
| Q59708035 | Risk Functions and the Primary Prevention of Cardiovascular Disease |
| Q37019601 | Risk assessment in the patient with established peripheral arterial disease |
| Q36906245 | Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications |
| Q37167780 | Role of lipoprotein-associated phospholipase A2 in atherosclerosis |
| Q37582800 | Secondary prevention strategies for coronary heart disease |
| Q33634769 | Serum C-reactive protein and procalcitonin kinetics in patients undergoing elective total hip arthroplasty. |
| Q39941673 | Serum amyloid A as a marker and mediator of acute coronary syndromes |
| Q35208820 | Serum metalloproteinases MMP-2, MMP-9, and metalloproteinase tissue inhibitors in patients are associated with arteriovenous fistula maturation |
| Q57824571 | Subclinical hypothyroidism is associated with lipid-rich plaques in patients with coronary artery disease as assessed by optical coherence tomography |
| Q26999377 | Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes |
| Q34091409 | Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men |
| Q36610558 | The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A. |
| Q34512225 | The Prevalence of Atherosclerosis in Those with Inflammatory Connective Tissue Disease by Race, Age, and Traditional Risk Factors |
| Q35138588 | The binding of monomeric C-reactive protein (mCRP) to Integrins αvβ3 and α4β1 is related to its pro-inflammatory action |
| Q35880875 | The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress |
| Q37580976 | The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention. |
| Q36737871 | The elusive link between high sensitivity C-reactive protein and carotid subclinical atherosclerosis in coronary artery bypass grafting candidates: a cross-sectional study |
| Q38776213 | The inflammatory inception of gallbladder cancer |
| Q37090943 | The use of high-sensitivity assays for C-reactive protein in clinical practice |
| Q37609631 | Thyroid hormone and atherosclerosis |
| Q37223957 | Use of biomarkers to develop treatment strategies for atherosclerosis |
| Q41611463 | Vein tissue expression of matrix metalloproteinase as biomarker for hemodialysis arteriovenous fistula maturation |
| Q48122630 | Your DNA is not your diagnosis: getting diagnoses right following secondary genomic findings. |
| Q36804819 | n-3 PUFA in CVD: influence of cytokine polymorphism |
Search more.